SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001493152-24-014506
Filing Date
2024-04-12
Accepted
2024-04-12 21:50:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13da.htm SC 13D/A 65089
  Complete submission text file 0001493152-24-014506.txt   66401
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Subject) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93147 | Film No.: 24842988
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CINGULATE INC. 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address
Werth Peter J. (Filed by) CIK: 0001883257 (see all company filings)

Type: SC 13D/A